How to correct the market for children’s cancer drugs - Nature Medicine

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Business News News

Business Business Latest News,Business Business Headlines

How to correct the market for children’s cancer drugs The development of pediatric cancer drugs is vastly underfunded compared with that for adults, but legislation can correct market failures. ChildhoodCancerAwarenessMonth CancerTherapy

My son, Jacob, could have been in one of those photos. At eight, Jacob was a boy whose passions were singing 1990s rock songs and playing baseball. One morning, he began to experience nausea and headaches.

Soon after, our world fell apart as Jacob was diagnosed with medulloblastoma, a pediatric cancer. I was stunned by the diagnosis, and I was shocked to learn that the cancer therapies available to treat Jacob were over 40 years old, and were unlikely to work. Jacob died two years later.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in BUSİNESS
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Business Business Latest News, Business Business Headlines